• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthTheranos

Arizona Is Getting Ready to Sue Theranos Over a ‘Long-Running Scheme of Deceptive Acts’

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
January 12, 2017, 4:50 PM ET
Forbes Under 30 Summit
Gilbert Carrasquillo Getty Images

It may be time to add another lawsuit to Silicon Valley upstart Theranos’ troubles.

Documents from Arizona’s Attorney General’s office indicate that the state is preparing to sue Elizabeth Holmes’ once-vaunted, now-dwindling blood testing outfit, the Wall Street Journal reports. The specific files are bidding proposals for outside counsel to represent the state in a lawsuit.

Click here to subscribe to Brainstorm Health Daily, our brand new newsletter about health innovations.

“The purpose of this contract is to retain Outside Counsel to aid the Arizona Attorney General’s Office (the AGO) in commencing legal action against Theranos, Inc. and its closely related subsidiaries for violations of the Arizona Consumer Fraud Act arising out of Theranos Inc.’s long-running scheme of deceptive acts and misrepresentations relating to the capabilities and operation of Theranos blood testing equipment, including but not limited to deceptive acts and misrepresentations made to Arizona consumers in connection with Theranos Wellness Centers in Arizona and California,” states the document.

Theranos operated about 40 “Wellness Centers” where it offered its blood testing services—services that ostensibly used diagnostic tech that Theranos claimed was revolutionary, but thousands of whose results the company had to eventually void for inaccuracies. The firm eventually decided to shut down its Wellness Centers and slash its workforce nearly in half in order to concentrate on a different technology called the “miniLab.”

Theranos is already facing a consumer class action suit over the inaccurate diagnostic results; a breach of contract suit by former partner Walgreens (WBA); and an investor class action alleging “continuous lies from the company’s CEO.”

Theranos told Fortune that is has “no comment” on the potential suit, and emphasized that it denies the allegations in the various other lawsuits currently under way.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

HealthDietary Supplements
The Best Colostrum Supplements 2026: Tested and Approved
By Emily PharesMarch 24, 2026
3 hours ago
Personal FinanceTaxes
Americans spend $146 billion and 11.6 billion hours doing their taxes, and most of it is just filling out paperwork
By Catherina GioinoMarch 24, 2026
3 hours ago
fauci
CommentaryCOVID-19 vaccines
How COVID turned America against science — and what it will take to win it back
By David Blumenthal and James A. MoroneMarch 24, 2026
14 hours ago
MagazineSocial Media
Inside the Seattle clinic that treats tech addiction like heroin, and clients detox for up to 16 weeks
By Kristin StollerMarch 24, 2026
16 hours ago
US President Donald Trump speaks to reporters before boarding Air Force One at Palm Beach International Airport in West Palm Beach, Florida, on March 23, 2026.
HealthIran
Trump has TACO’d again, this time in Iran, sparking a $1.7 trillion stock market rally in minutes, even as peace talks are in question
By Eva RoytburgMarch 23, 2026
1 day ago
HealthHealth
Forest ‘bathing’ can reduce stress, improve mood, lower blood pressure and boost the immune system. Here’s how it’s done
By Allen Breed and The Associated PressMarch 22, 2026
2 days ago

Most Popular

Commentary
The Treasury just declared the U.S. insolvent. The media missed it
By Fortune EditorsMarch 23, 2026
1 day ago
Personal Finance
Current price of gold as of March 23, 2026
By Fortune EditorsMarch 23, 2026
1 day ago
Economy
It took 200 years for national debt to hit $1 trillion. Annual interest alone now exceeds that—a 'crushing legacy we must reverse,' says budget chair
By Fortune EditorsMarch 23, 2026
1 day ago
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strong
By Fortune EditorsMarch 24, 2026
15 hours ago
Economy
Larry Fink says today's economic anxiety stems from people increasingly feeling like capitalism isn't working for them
By Fortune EditorsMarch 23, 2026
1 day ago
Personal Finance
Current price of silver as of Tuesday, March 24, 2026
By Fortune EditorsMarch 24, 2026
11 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.